Joseph Wels, MD
- 3Articles
- 34.7KReads1
- 2017–2020Active
- 13Collaborators
- 220Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Joseph Wels, MD, is affiliated with the Mental Health Service Line at the Minneapolis VA Health Care System and the University of Minnesota Medical School. His publications from 2017 to 2020 focus on depression, particularly treatment-resistant depression, and posttraumatic stress disorder (PTSD). His research includes studies on intravenous ketamine combined with prolonged exposure therapy in veterans, the safety and efficacy of repeated ketamine infusions for comorbid PTSD and depression, and the impact of concurrent benzodiazepine use on ketamine's antidepressant effects. He has frequently collaborated with Paul Thuras, Paulo R. Shiroma, C. Sophia Albott, Christopher Erbes, and Kelvin O. Lim.
Publications
Ketamine Plus Prolonged Exposure Therapy for Veterans With PTSD
November 10, 2020
Repeated Ketamine Infusions for Comorbid PTSD and TRD
May 1, 2018
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
